Literature DB >> 23609472

Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies.

Sarah A Aroner1, Laura C Collins, James L Connolly, Graham A Colditz, Stuart J Schnitt, Bernard A Rosner, Susan E Hankinson, Rulla M Tamimi.   

Abstract

Radial scars (RS) are benign proliferative lesions associated with an increased risk of subsequent breast cancer. However, it remains unclear whether RS are an independent risk factor for breast cancer or whether their association with breast cancer is due to their common occurrence with other proliferative lesions known to increase breast cancer risk. We performed an updated analysis of the association between RS and subsequent breast cancer risk in a nested case-control study among 460 cases and 1,792 controls with benign breast disease (BBD) in the Nurses' Health Studies. Logistic regression was used to estimate associations between RS in BBD biopsy specimens and breast cancer risk, adjusted for matching factors and breast cancer risk factors, including histologic category of concurrent BBD. In multivariable models prior to adjustment for histologic category of BBD, RS were associated with a twofold increased risk of breast cancer (odds ratio (OR) = 2.0; 95 % confidence interval (95 % CI) 1.4, 2.8). This association was attenuated but still significant after adjustment for BBD histologic category (OR = 1.6; 95 % CI 1.1, 2.3). In models adjusted for BBD histologic category and other covariates, risk appeared greater among women with multiple RS (1 RS, OR = 1.5; 95 % CI 0.9, 2.3; ≥2 RS, OR = 2.7; 95 % CI 1.5, 5.0; p-heterogeneity = 0.12). There were also suggestions of a greater risk associated with RS among women age ≥50 years at biopsy (p-heterogeneity = 0.07) and for estrogen receptor-negative/progesterone receptor-negative tumors compared with other hormone receptor subtypes (p-heterogeneity = 0.19). RS appear to be an independent histologic risk factor for breast cancer. Larger studies are needed to further evaluate whether risk is increased when multiple RS are present and whether associations vary by age at biopsy or by hormone receptor status of the breast tumor.

Entities:  

Mesh:

Year:  2013        PMID: 23609472      PMCID: PMC3689547          DOI: 10.1007/s10549-013-2535-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  32 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Atypical hyperplastic lesions of the female breast. A long-term follow-up study.

Authors:  D L Page; W D Dupont; L W Rogers; M S Rados
Journal:  Cancer       Date:  1985-06-01       Impact factor: 6.860

3.  A nonencapsulated sclerosing lesion of the breast.

Authors:  E R Fisher; A S Palekar; N Kotwal; N Lipana
Journal:  Am J Clin Pathol       Date:  1979-03       Impact factor: 2.493

4.  Breast carcinoma. Aspects of early stages, progression and related problems.

Authors:  F Linell; O Ljungberg; I Andersson
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1980

5.  Subgross pathologic features and incidence of radial scars in the breast.

Authors:  S R Wellings; C E Alpers
Journal:  Hum Pathol       Date:  1984-05       Impact factor: 3.466

Review 6.  Tubular carcinoma of the breast: an institutional experience and review of the literature.

Authors:  Amadeo H Cabral; Monica Recine; Juan C Paramo; Michael M McPhee; Robert Poppiti; Thomas W Mesko
Journal:  Breast J       Date:  2003 Jul-Aug       Impact factor: 2.431

7.  CD34+ fibrocytes in tubular carcinomas and radial scars of the breast.

Authors:  Annette Ramaswamy; Roland Moll; Peter J Barth
Journal:  Virchows Arch       Date:  2003-07-29       Impact factor: 4.064

8.  A prospective study of benign breast disease and the risk of breast cancer.

Authors:  S J London; J L Connolly; S J Schnitt; G A Colditz
Journal:  JAMA       Date:  1992-02-19       Impact factor: 56.272

9.  Molecular and genetic abnormalities in radial scar.

Authors:  Mussawar Iqbal; Balvinder S Shoker; Christopher S Foster; Christine Jarvis; D Ross Sibson; Michael P A Davies
Journal:  Hum Pathol       Date:  2002-07       Impact factor: 3.466

10.  Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.

Authors:  Rulla M Tamimi; Heather J Baer; Jonathan Marotti; Mark Galan; Laurie Galaburda; Yineng Fu; Anne C Deitz; James L Connolly; Stuart J Schnitt; Graham A Colditz; Laura C Collins
Journal:  Breast Cancer Res       Date:  2008-08-05       Impact factor: 6.466

View more
  12 in total

Review 1.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

2.  Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile.

Authors:  Carey A Eberle; Salvatore Piscuoglio; Emad A Rakha; Charlotte K Y Ng; Felipe C Geyer; Marcia Edelweiss; Rita A Sakr; Britta Weigelt; Jorge S Reis-Filho; Ian O Ellis
Journal:  Histopathology       Date:  2016-01-07       Impact factor: 5.087

Review 3.  Radial Scar: a management dilemma.

Authors:  Charlotte Marguerite Lucille Trombadori; Anna D'Angelo; Francesca Ferrara; Angela Santoro; Paolo Belli; Riccardo Manfredi
Journal:  Radiol Med       Date:  2021-03-20       Impact factor: 3.469

4.  Subtypes of Benign Breast Disease as a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis Protocol.

Authors:  Manoosh Zendehdel; Babak Niakan; Abbasali Keshtkar; Elahe Rafiei; Fatemeh Salamat
Journal:  Iran J Med Sci       Date:  2018-01

5.  EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.

Authors:  Francisco Beca; Kevin Kensler; Benjamin Glass; Stuart J Schnitt; Rulla M Tamimi; Andrew H Beck
Journal:  Breast Cancer Res       Date:  2017-03-02       Impact factor: 6.466

6.  Deep Learning Image Analysis of Benign Breast Disease to Identify Subsequent Risk of Breast Cancer.

Authors:  Adithya D Vellal; Korsuk Sirinukunwattan; Kevin H Kensler; Gabrielle M Baker; Andreea L Stancu; Michael E Pyle; Laura C Collins; Stuart J Schnitt; James L Connolly; Mitko Veta; A Heather Eliassen; Rulla M Tamimi; Yujing J Heng
Journal:  JNCI Cancer Spectr       Date:  2021-01-11

7.  Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk.

Authors:  Rulla M Tamimi; Yujing J Heng; Kevin H Kensler; Emily Z F Liu; Suzanne C Wetstein; Allison M Onken; Christina I Luffman; Gabrielle M Baker; Laura C Collins; Stuart J Schnitt; Vanessa C Bret-Mounet; Mitko Veta; Josien P W Pluim; Ying Liu; Graham A Colditz; A Heather Eliassen; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-11       Impact factor: 4.254

8.  Radial scars and subsequent breast cancer risk: a meta-analysis.

Authors:  Mengmeng Lv; Xingya Zhu; Shanliang Zhong; Weixian Chen; Qing Hu; Tengfei Ma; Jun Zhang; Xiaohui Zhang; Jinhai Tang; Jianhua Zhao
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

Review 9.  Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses.

Authors:  Fatemeh Salamat; Babak Niakan; Abbasali Keshtkar; Elahe Rafiei; Manoosh Zendehdel
Journal:  Iran J Med Sci       Date:  2018-07

10.  Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk.

Authors:  Suzanne C Wetstein; Allison M Onken; Christina Luffman; Gabrielle M Baker; Michael E Pyle; Kevin H Kensler; Ying Liu; Bart Bakker; Ruud Vlutters; Marinus B van Leeuwen; Laura C Collins; Stuart J Schnitt; Josien P W Pluim; Rulla M Tamimi; Yujing J Heng; Mitko Veta
Journal:  PLoS One       Date:  2020-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.